drugset / Trial / NCT02724267

Targeted Internal Radiation Therapy in Advanced HCC Patients.

NCT02724267 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the 131I-chTNT-1/B treatment effect and safety of individual therapy using randomized controlled study, in order to acquire the evidence of evidence-based medicine and create a new program of targeted internal radiation therapy in advanced HCC patients.

Timeline

Start
2012-11
Primary completion
2015-06
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 131I-chTNT-1/B Unknown 29.6 mbq/kg Intravenous